High-dose rifaximin treatment alleviates global symptoms of irritable bowel syndrome

BACKGROUND: To evaluate the efficacy of rifaximin for reduction of gastrointestinal symptoms in patients with irritable bowel syndrome (IBS). METHODS: Medical records were identified for consecutive patients diagnosed with IBS according to Rome III criteria, who had abnormal lactulose breath test re...

Descripción completa

Detalles Bibliográficos
Autor principal: Jolley, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108677/
https://www.ncbi.nlm.nih.gov/pubmed/21694871
http://dx.doi.org/10.2147/CEG.S18051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108677/
https://www.ncbi.nlm.nih.gov/pubmed/21694871
http://dx.doi.org/10.2147/CEG.S18051

Ejemplares similares